Titrated Disease Management for Patients With Hypertension

NCT01390272 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 385

Last updated 2019-02-11

Study results available
· View outcomes & findings →

Summary

This randomized clinical trial examines whether programs aimed at matching resources to patient hypertension (i.e. high blood pressure) control lead to greater reduction in systolic blood pressure (top number of blood pressure reading) than simply having maintenance phone calls in addition to usual care. Answering this question will provide important evidence concerning the overall goal of sustained long-term implementation of the disease management programs as part of patient aligned care teams in the Veterans Affairs and other healthcare systems.

Conditions

Interventions

BEHAVIORAL

Booster/ low resource

A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.

BEHAVIORAL

Booster/ low resource

A LPN will provide behavioral support telephone calls that do not include goal setting and directed problem solving every two months.

BEHAVIORAL

Medium/Level 1 resource intensity

Monthly tailored RN delivered calls + home BP monitoring.

BEHAVIORAL

High/Level 2 resource intensity

Pharmacist delivered telephone behavioral self-management support + Home BP monitoring with feedback to pharmacist + Algorithmic medication changes directed by pharmacist (with physician backup).

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • George L Jackson, PhD MHA · Durham VA Medical Center, Durham, NC

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-27
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390272 on ClinicalTrials.gov